Article Details
Retrieved on: 2021-03-30 21:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Monoclonal antibody bamlanivimab appeared to work for end-stage renal disease (ESRD) patients in early data from dialysis providers, but there are ...
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here